Core binding factor (CBF)-AML was inversely correlated with CD33 expression [16,18] and the authors speculated that the initial event, t(8;21)/inv(16)/t(16.16), occurred very early in pre-leukemic CD33-negative cells [68]. Here, CD33 is linked to acute myeloid leukemia.